← Product Code [FAD](/submissions/GU/subpart-e%E2%80%94surgical-devices/FAD) · K063742 # RESONANCE METALLIC URETERAL STENT (K063742) _Cook Ireland, Ltd. · FAD · May 8, 2007 · Gastroenterology, Urology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/GU/subpart-e%E2%80%94surgical-devices/FAD/K063742 ## Device Facts - **Applicant:** Cook Ireland, Ltd. - **Product Code:** [FAD](/submissions/GU/subpart-e%E2%80%94surgical-devices/FAD.md) - **Decision Date:** May 8, 2007 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 876.4620 - **Device Class:** Class 2 - **Review Panel:** Gastroenterology, Urology - **Attributes:** Therapeutic ## Indications for Use Used for temporary stenting of the ureter in adult patients with extrinsic ureteral obstruction. Intended for one-time use only. ## Device Story Resonance™ Metallic Ureteral Stent is a metallic device designed to maintain urine flow from kidney to bladder in patients with obstructive ureteral pathology. Placed by physicians via endoscopic retrograde or percutaneous antegrade insertion. Stent extends from renal pelvis through ureter to bladder. Provides mechanical support to bypass obstructions; facilitates drainage. Used in clinical settings; intended for temporary, one-time use. ## Clinical Evidence Clinical testing was conducted to gather information on adverse events and stent function. Non-clinical bench testing included flow, elongation/yield, tensile strength, stent migration, and retention testing. ## Technological Characteristics Metallic ureteral stent; designed for temporary drainage of the ureter. Dimensions and specific metallic alloy composition not detailed in summary. Mechanical principle of operation for maintaining ureteral patency. Single-use device. ## Regulatory Identification A ureteral stent is a tube-like implanted device that is inserted into the ureter to provide ureteral rigidity and allow the passage of urine. The device may have finger-like protrusions or hooked ends to keep the tube in place. It is used in the treatment of ureteral injuries and ureteral obstruction. ## Predicate Devices - Bioteq Double Pigtail Ureteral Stent set ([K033210](/device/K033210.md)) - Cook Endo-Sof™ Double Pigtail Stent ([K961446](/device/K961446.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ 1 an 1 age 1 un 1 1 Section 5.0 510(k) Summary ## K063742 Name: Address: Phone: Contact Persons: Fax: Cook Ireland Ltd O'Halloran Road National Technology Park Limerick, Ireland 353 61 334440 353 61 334441 Emmett Devereux, Quality & Regulatory Manager Sinead Burke, Regulatory Affairs Supervisor 353 61 334440 353 61 334441 December 14, 2006 Resonance™ Metallic Ureteral stent Ureteral stent Stent, ureteral Bioteq Double Pigtail Ureteral Stent set (K033210) Cook Endo-Sof™ Double Pigtail Stent (K961446) The Resonance™ Metallic ureteral stent is a device which is intended to achieve normal urine flow from the kidney to the urinary bladder in situations where obstructive pathological processes prevent it. The stent extends from the renal pelvis to the urinary bladder via the ureter and is placed by either endoscopic retrograde or percutaneous antegrade insertion. Phone: Fax: Date: Trade Name: Common Name: Classification Name: Legally Marketed Devices: Description of the Device: **MAY 8 2007** {1}------------------------------------------------ Comparison of Characteristics: Indications for use: Used for temporary stenting of the ureter in adult patients with extrinsic ureteral obstruction. Intended for one-time use only. > We believe the proposed device the Resonance TM Metallic ureteral stent to be substantially equivalent to the currently marketed predicate devices Bioteq Double Pigtail Ureteral Stent set as cleared by (K033210) and Endo-Sof™ Double Pigtail Stent as cleared under (K961446). > Non clinical testing was carried out on the stent to determine the equivalence of the Resonance TM Metallic ureteral stent to the predicate devices and to verify the safety and effectiveness of the stent. The following is a summary of the testing carried out: flow, elongation / yield and tensile strength, stent migration and retention. > Clinical testing was carried out to primarily gather information on adverse events and stent function. Performance Data: {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows a logo for the Department of Health & Human Services. The logo consists of a stylized eagle with three lines representing its body and wings. The text "DEPARTMENT OF HEALTH & HUM." is arranged in a circular fashion around the eagle. ## MAY 8 2007 Food and Drug Administration 9200 Corporate Blvd. Rockville MD 20850 Ms. Sinead Burke Regulatory Affairs Supervisor Cook Ireland Ltd. O'Halloran Road National Technology Park Limerick IRELAND K063742 Re: Trade/Device Name: Resonance™ Metallic Ureteral Stent Regulation Number: 21 CFR §876.4620 Regulation Name: Ureteral stent Regulatory Class: II Product Code: FAD Dated: April 23, 2007 Received: April 26, 2007 Dear Ms. Burke: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Image /page/2/Picture/10 description: The image is a circular logo or emblem. The text "1906-2006" is at the top of the circle. The letters "FDA" are in the center of the circle in a bold, stylized font. Below the letters, the word "Centennial" is written in a cursive font. Three stars are at the bottom of the circle. Protecting and Promoting Public Health {3}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter: | 21 CFR 876.xxxx | (Gastroenterology/Renal/Urology) | 240-276-0115 | |-----------------|----------------------------------|--------------| | 21 CFR 884.xxxx | (Obstetrics/Gynecology) | 240-276-0115 | | 21 CFR 892.xxxx | (Radiology) | 240-276-0120 | | Other | | 240-276-0100 | Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html Sincerely yours, Nancy C. Brogdon Nancy C. Brogdon Director. Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ## Section 4.0 Indications for Use 510(k) Number (if known): KN63742 Device Name: Resonance™ Metallic Ureteral stent Indications for Use: Used for temporary stenting of the ureter in adult patients with extrinsic ureteral obstruction. Intended for one-time use only. Prescription Use Over-The-Counter Use AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Nancy C Boydon (Division Sign-Off) Division of Reproductive, Abdominal, and Radiological Devices 510(k) Number Page 1 of 1 --- **Source:** [https://fda.innolitics.com/submissions/GU/subpart-e%E2%80%94surgical-devices/FAD/K063742](https://fda.innolitics.com/submissions/GU/subpart-e%E2%80%94surgical-devices/FAD/K063742) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com